Skip to main content
Top
Published in: BMC Nephrology 1/2021

Open Access 01-12-2021 | Case report

INF2 p.Arg214Cys mutation in a Chinese family with rapidly progressive renal failure and follow-up of renal transplantation: case report and literature review

Authors: Wenbo Zhao, Xinxin Ma, Xiaohao Zhang, Dan Luo, Jun Zhang, Ming Li, Zengchun Ye, Hui Peng

Published in: BMC Nephrology | Issue 1/2021

Login to get access

Abstract

Background

Heterozygous mutations in the inverted formin 2 (INF2) gene are related to secondary focal segmental glomerulosclerosis (FSGS), a rare secondary disease associated with rapidly progressive renal failure.

Case presentation

We report a patient with familial autosomal INF2 mutation manifesting nephritic syndromes and elevated serum creatinine levels. Mutational analysis revealed an autosomal dominant (AD) inheritance pattern and a mutation in exon 4 (p.Arg214Cys) of INF2 as the likely cause, which has not been previously described in an Asian family. The patient progressed to end-stage renal disease (ESRD) and received hemodialysis. His mother had undergone renal transplant 3 years earlier, and his grandmother had carried the p.Arg214Cys mutation for more than 80 years without any sign of renal dysfunction.

Conclusions

This is the first report to identify an association between a familial autosomal dominant INF2 p.Arg214Cys mutation and rapidly progressive renal disease in an Asian family. INF2 mutation analysis should not be restricted to individuals without family history of FSGS, rather it should also be performed on individuals for whom drug-based therapies are not effective. In this case, kidney transplant is an effective alternative.
Literature
1.
go back to reference Goode BL, Eck MJ. Mechanism and function of formins in the control of actin assembly. Annu Rev Biochem. 2007;76:593–627.CrossRef Goode BL, Eck MJ. Mechanism and function of formins in the control of actin assembly. Annu Rev Biochem. 2007;76:593–627.CrossRef
2.
go back to reference Labat-de-Hoz L, Alonso MA. The formin INF2 in disease: progress from 10 years of research. Cell Mol Life Sci. 2020;77:4581–600.CrossRef Labat-de-Hoz L, Alonso MA. The formin INF2 in disease: progress from 10 years of research. Cell Mol Life Sci. 2020;77:4581–600.CrossRef
3.
go back to reference Brown EJ, Schlöndorff JS, Becker DJ, Tsukaguchi H, Tonna SJ, Uscinski AL, et al. Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis. Nat Genet. 2010;42:72–6.CrossRef Brown EJ, Schlöndorff JS, Becker DJ, Tsukaguchi H, Tonna SJ, Uscinski AL, et al. Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis. Nat Genet. 2010;42:72–6.CrossRef
4.
go back to reference Boyer O, Benoit G, Gribouval O, Nevo F, Tête MJ, Dantal J, et al. Mutations in INF2 are a major cause of autosomal dominant focal segmental glomerulosclerosis. J Am Soc Nephrol. 2011;22:239–45.CrossRef Boyer O, Benoit G, Gribouval O, Nevo F, Tête MJ, Dantal J, et al. Mutations in INF2 are a major cause of autosomal dominant focal segmental glomerulosclerosis. J Am Soc Nephrol. 2011;22:239–45.CrossRef
5.
go back to reference Boyer O, Nevo F, Plaisier E, Funalot B, Gribouval O, Benoit G, et al. INF2 mutations in Charcot-Marie-tooth disease with glomerulopathy. N Engl J Med. 2011;365:2377–88.CrossRef Boyer O, Nevo F, Plaisier E, Funalot B, Gribouval O, Benoit G, et al. INF2 mutations in Charcot-Marie-tooth disease with glomerulopathy. N Engl J Med. 2011;365:2377–88.CrossRef
6.
go back to reference Gbadegesin RA, Lavin PJ, Hall G, Bartkowiak B, Homstad A, Jiang R, et al. Inverted formin 2 mutations with variable expression in patients with sporadic and hereditary focal and segmental glomerulosclerosis. Kidney Int. 2012;81:94–9.CrossRef Gbadegesin RA, Lavin PJ, Hall G, Bartkowiak B, Homstad A, Jiang R, et al. Inverted formin 2 mutations with variable expression in patients with sporadic and hereditary focal and segmental glomerulosclerosis. Kidney Int. 2012;81:94–9.CrossRef
7.
go back to reference Münch J, Grohmann M, Lindner TH, Bergmann C, Halbritter J. Diagnosing FSGS without kidney biopsy - a novel INF2-mutation in a family with ESRD of unknown origin. BMC Med Genet. 2016;17:73.CrossRef Münch J, Grohmann M, Lindner TH, Bergmann C, Halbritter J. Diagnosing FSGS without kidney biopsy - a novel INF2-mutation in a family with ESRD of unknown origin. BMC Med Genet. 2016;17:73.CrossRef
8.
go back to reference Echaniz-Laguna A, Latour P. A cryptic splicing mutation in the INF2 gene causing Charcot-Marie-tooth disease with minimal glomerular dysfunction. J Peripher Nerv Syst. 2019;24:120–4.CrossRef Echaniz-Laguna A, Latour P. A cryptic splicing mutation in the INF2 gene causing Charcot-Marie-tooth disease with minimal glomerular dysfunction. J Peripher Nerv Syst. 2019;24:120–4.CrossRef
9.
go back to reference Caridi G, Lugani F, Dagnino M, Gigante M, Iolascon A, Falco M, et al. Novel INF2 mutations in an Italian cohort of patients with focal segmental glomerulosclerosis, renal failure and Charcot-Marie-tooth neuropathy. Nephrol Dial Transplant. 2014;29(Suppl 4):iv80–6.CrossRef Caridi G, Lugani F, Dagnino M, Gigante M, Iolascon A, Falco M, et al. Novel INF2 mutations in an Italian cohort of patients with focal segmental glomerulosclerosis, renal failure and Charcot-Marie-tooth neuropathy. Nephrol Dial Transplant. 2014;29(Suppl 4):iv80–6.CrossRef
10.
go back to reference Mademan I, Deconinck T, Dinopoulos A, Voit T, Schara U, Devriendt K, et al. De novo INF2 mutations expand the genetic spectrum of hereditary neuropathy with glomerulopathy. Neurology. 2013;81:1953–8.CrossRef Mademan I, Deconinck T, Dinopoulos A, Voit T, Schara U, Devriendt K, et al. De novo INF2 mutations expand the genetic spectrum of hereditary neuropathy with glomerulopathy. Neurology. 2013;81:1953–8.CrossRef
11.
go back to reference Bayraktar S, Nehrig J, Menis E, Karli K, Janning A, Struk T, et al. A deregulated stress response underlies distinct INF2-associated disease profiles. J Am Soc Nephrol. 2020;31:1296–313.CrossRef Bayraktar S, Nehrig J, Menis E, Karli K, Janning A, Struk T, et al. A deregulated stress response underlies distinct INF2-associated disease profiles. J Am Soc Nephrol. 2020;31:1296–313.CrossRef
12.
go back to reference Paul MD, Fernandez D, Pryse-Phillips W, Gault MH. Charcot-Marie-tooth disease and nephropathy in a mother and daughter with a review of the literature. Nephron. 1990;54:80–5.CrossRef Paul MD, Fernandez D, Pryse-Phillips W, Gault MH. Charcot-Marie-tooth disease and nephropathy in a mother and daughter with a review of the literature. Nephron. 1990;54:80–5.CrossRef
13.
go back to reference De Rechter S, De Waele L, Levtchenko E, Mekahli D. Charcot-Marie-tooth: are you testing for proteinuria. Eur J Paediatr Neurol. 2015;19:1–5.CrossRef De Rechter S, De Waele L, Levtchenko E, Mekahli D. Charcot-Marie-tooth: are you testing for proteinuria. Eur J Paediatr Neurol. 2015;19:1–5.CrossRef
14.
go back to reference Rodriguez PQ, Lohkamp B, Celsi G, Mache CJ, Auer-Grumbach M, Wernerson A, et al. Novel INF2 mutation p. L77P in a family with glomerulopathy and Charcot-Marie-tooth neuropathy. Pediatr Nephrol. 2013;28:339–43.CrossRef Rodriguez PQ, Lohkamp B, Celsi G, Mache CJ, Auer-Grumbach M, Wernerson A, et al. Novel INF2 mutation p. L77P in a family with glomerulopathy and Charcot-Marie-tooth neuropathy. Pediatr Nephrol. 2013;28:339–43.CrossRef
15.
go back to reference Chhabra ES, Ramabhadran V, Gerber SA, Higgs HN. INF2 is an endoplasmic reticulum-associated formin protein. J Cell Sci. 2009;122:1430–40.CrossRef Chhabra ES, Ramabhadran V, Gerber SA, Higgs HN. INF2 is an endoplasmic reticulum-associated formin protein. J Cell Sci. 2009;122:1430–40.CrossRef
16.
go back to reference Lee HK, Han KH, Jung YH, Kang HG, Moon KC, Ha IS, et al. Variable renal phenotype in a family with an INF2 mutation. Pediatr Nephrol. 2011;26:73–6.CrossRef Lee HK, Han KH, Jung YH, Kang HG, Moon KC, Ha IS, et al. Variable renal phenotype in a family with an INF2 mutation. Pediatr Nephrol. 2011;26:73–6.CrossRef
17.
go back to reference Barua M, Brown EJ, Charoonratana VT, Genovese G, Sun H, Pollak MR. Mutations in the INF2 gene account for a significant proportion of familial but not sporadic focal and segmental glomerulosclerosis. Kidney Int. 2013;83:316–22.CrossRef Barua M, Brown EJ, Charoonratana VT, Genovese G, Sun H, Pollak MR. Mutations in the INF2 gene account for a significant proportion of familial but not sporadic focal and segmental glomerulosclerosis. Kidney Int. 2013;83:316–22.CrossRef
Metadata
Title
INF2 p.Arg214Cys mutation in a Chinese family with rapidly progressive renal failure and follow-up of renal transplantation: case report and literature review
Authors
Wenbo Zhao
Xinxin Ma
Xiaohao Zhang
Dan Luo
Jun Zhang
Ming Li
Zengchun Ye
Hui Peng
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2021
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-021-02254-9

Other articles of this Issue 1/2021

BMC Nephrology 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.